Brief: Galecto Inc Entered Into Collaboration Agreement For Investigator-Initiated Phase 2

Damora Therapeutics

19/10/2022 13:10

Oct 19 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO - COLLABORATION AGREEMENT FOR
INVESTIGATOR-INITIATED
PHASE 2 TRIAL AT PROVIDENCE PORTLAND MEDICAL CENTER'S EARLE A.
CHILES RESEARCH INSTITUTE
    * GALECTO INC - COMMITTED TO SUPPLY GB1211 FOR PHASE 2 TRIAL
    * GALECTO INC - PHASE 2 TRIAL IS EXPECTED TO BEGIN IN 2023
AND TOP
LINE RESULTS OF COMBINATION ARE EXPECTED TO BE REPORTED AS EARLY
AS 2025

Source text for Eikon:  ID:nGNX7XmYYF 
Further company coverage:  GLTO.O 
 ((Reuters.Briefs@thomsonreuters.com;))